arrow
B

Brittany Bychkovsky

dana-farber/brigham cancer center
H指数:16
被引数:2,110

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Frequency and clinical features of germline pathogenic variants in sarcoma: a case-control study

Rodriguez-Hernandez, A.; Horiguchi, M.; Horton, C.; Polfus, L.M.; Bychkovsky, B.L.; Buehler, R.M.; George, S.; Merriam, P.; Garber, J.E.; Rana, H.Q. 软组织肉瘤中胚系致病性变异的频率及临床特征:一项病例对照研究。J. Natl. Cancer Inst. 2026, 118, 150–159. [Google Scholar] [CrossRef]

2025-12-011
PRE
ASO Visual Abstract: Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy Rates

ASO视觉摘要:美国乳腺外科医师学会指南对遗传检测和对侧预防性乳房切除术率的影响

2025-05-120
PRE
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome (vol 211, 114307, 2024)

HER2状态和乳腺癌患者及Li-Fraumeni综合征患者对新辅助抗HER2治疗的反应(卷211,114307,2024)

2025-05-010
PRE
Are contralateral prophylactic mastectomy rates impacted by ASBrS guidelines to offer germline genetic testing to all patients with breast cancer? Results from a large, prospective, singleinstitution cohort
2024-05-020
PRE
Comprehensive clinicogenomic characterization of inflammatory breast cancer
2024-05-020
PRE
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer
2024-04-160
OAAI
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer (vol 14, 7496, 2023)

HER2-low和HER2-0乳腺癌的综合基因组特征 (第14,7496,2023卷)

2023-12-140
OAAI
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

HER2-low和HER2-0乳腺癌的综合基因组特征

2023-11-1819
OAAI
Somatic alterations in primary tumors of patients (pts) with metastatic breast cancer (MBC) may predict likelihood of brain metastasis
2023-03-010
PRE